Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 11,376–11,400 of 27,380 studies, newest first · page 456 of 1096.

July 2020 25

  1. 2020-07-29

    Artificial Intelligence in Health Care: Bibliometric Analysis

    ✓ Peer-reviewed Digital health tools Journal of medical Internet research

    Key finding: This analysis provides a comprehensive overview of the AI-related research conducted in the field of health care, which helps researchers, policy makers, and practitioners better understand the development of health care-related AI research and possible practice implications. +1 more finding

  2. 2020-07-29

    Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer's disease mouse model

    ✓ Peer-reviewed Disease mechanisms Science advances

    Key finding: We show that gut dysbiosis occurs in 5xFAD mice, and is associated with escalation of the C/EBPβ/AEP pathway in the gut with age. +1 more finding

  3. 2020-07-29

    It's complicated: The relationship between sleep and Alzheimer's disease in humans

    ✓ Peer-reviewed Disease mechanisms Neurobiology of disease

    Key finding: Sleep disturbances have been associated with increased future risk of AD. +1 more finding

  4. 2020-07-29

    Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia

    ✓ Peer-reviewed Prevention and risk Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: We present the results of the 5th CCCDTD, which convened in October 2019, to address topics chosen by the steering committee to reflect advances in the field, and build on previous guidelines.

  5. 2020-07-28

    Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: We included 201 individuals (mean age 73.5 years, mean BMI 27.4 kg/m2). +3 more findings

  6. 2020-07-27

    Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches

    ✓ Peer-reviewed Disease mechanisms The Lancet. Neurology

    Key finding: However, emerging evidence from human and animal studies indicate that insulin influences cerebral bioenergetics, enhances synaptic viability and dendritic spine formation, and increases turnover of neurotransmitters, such as dopamine.

  7. 2020-07-27

    Healthy brain, healthy life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer's disease risk

    ✓ Peer-reviewed Prevention trials Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

    Key finding: With the world's population aging at a rapid rate, the prevalence of Alzheimer's disease (AD) has significantly increased. +1 more finding

  8. 2020-07-27

    A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: PE-treated patients performed significantly better than placebo for the co-primary endpoints: change from baseline of Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL; P = .03; 52% less decline) with a trend for Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog; P = .06; 66% less decline) scores at month 14. +3 more findings

  9. 2020-07-27

    Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

    ✓ Peer-reviewed Getting a diagnosis Acta neuropathologica

    Key finding: The results demonstrate that plasma p-tau181 associates better with AD neuropathology and Braak staging than a clinical diagnosis 8 years before post-mortem. +3 more findings

  10. 2020-07-25

    Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Neurobiology of aging

    Key finding: We found that the concentration of NfL in CSF, but not in plasma, was increased in response to Aβ pathology in CU subjects. +2 more findings

  11. 2020-07-25

    Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Molecular neurodegeneration

    Key finding: Our results demonstrate that novel AD biomarker candidates are identified and confirmed by proteomic studies of brain tissue and biofluids, providing a rich resource for large-scale biomarker validation for the AD community. +2 more findings

  12. 2020-07-25

    Antihypertensive Deprescribing in Older Adult Veterans at End of Life Admitted to Veteran Affairs Nursing Homes

    ✓ Peer-reviewed End-of-life care Journal of the American Medical Directors Association

    Key finding: Real-world deprescribing patterns of antihypertensives among NH residents with HTN and LLE/AD appear to reflect variation in recommendations for HTN treatment intensity and individualization of patient care in a population with potential overtreatment. +4 more findings

  13. 2020-07-25
  14. 2020-07-24

    Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in integrative neuroscience

    Key finding: Patient and animal model studies have found that abnormal protein aggregation of Aβ, synuclein, or copper-zinc superoxide dismutase-1 (SOD1), which are the main proteins expressed in the three diseases, respectively, can activate microglial cells, induce increased interleukin-1β (IL-1β) release, and activate the NLRP3 pathway, leading to neurodegeneration. +4 more findings

  15. 2020-07-24

    Neuroinflammation, microglial activation, and glucose metabolism in neurodegenerative diseases

    ✓ Peer-reviewed Risk factors International review of neurobiology

    Key finding: Apart from the plaques and tangles, microglial activation plays a significant role in neurodegeneration and neuronal function.

  16. 2020-07-24

    Multifunctional roles of zinc in Alzheimer's disease

    ✓ Peer-reviewed Drug development Neurotoxicology

    Key finding: Emerging evidence demonstrates that zinc is also widely associated with the development of AD. +1 more finding

  17. 2020-07-24

    Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging

    ✓ Peer-reviewed Genetics Translational psychiatry

    Key finding: Most people's cognitive abilities decline with age, with significant and partly genetically driven, individual differences in rate of change. +2 more findings

  18. 2020-07-24

    Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

    ✓ Peer-reviewed Disease mechanisms Nature reviews. Drug discovery

    Key finding: The brain requires a continuous supply of energy in the form of ATP, most of which is produced from glucose by oxidative phosphorylation in mitochondria, complemented by aerobic glycolysis in the cytoplasm. +4 more findings

  19. 2020-07-24

    Leading Chronic Disease Prevention With Evidence-Based Policy: The ASTHO Example

    ✓ Peer-reviewed Risk factors Journal of Public Health Management and Practice

    Key finding: Many S/THOs focus on improving chronic disease risk factors because of the significant human burden and cost of these conditions. +2 more findings

  20. 2020-07-24

    Digital Biomarkers for the Early Detection of Mild Cognitive Impairment: Artificial Intelligence Meets Virtual Reality

    ✓ Peer-reviewed Digital health tools Frontiers in human neuroscience

    Key finding: VR can be used to create highly ecologically controlled simulations resembling the daily life contexts in which patients' daily instrumental activities (IADL) usually take place. +4 more findings

  21. 2020-07-23

    Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis

    ✓ Peer-reviewed Disease mechanisms Cell death and differentiation

    Key finding: We found that urolithin A-lowered mitochondrial calcium influx significantly alleviated high glucose-induced mtROS accumulation and expression of amyloid beta (Aβ)-producing enzymes, such as amyloid precursor protein (APP) and β-secretase-1 (BACE1), as well as Aβ production. +2 more findings

  22. 2020-07-23

    Health Care Costs of Alzheimer’s and Related Dementias Within a Medicare Managed Care Provider

    ✓ Peer-reviewed Health systems and care delivery Medical Care

    Key finding: Total monthly health care costs for individuals with ADRD are statistically greater (P<0.05) than controls beginning in the third month before diagnosis and remain significantly greater through the eighth month following diagnosis. +3 more findings

  23. 2020-07-23

    Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice

    ✓ Peer-reviewed TREM2 and immune genetics Molecular neurodegeneration

    Key finding: Alzheimer's Disease (AD) is a neurodegenerative disorder influenced by aging and genetic risk factors. +3 more findings

  24. 2020-07-22

    Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration

    ✓ Peer-reviewed Down syndrome and Alzheimer's Antioxidants (Basel, Switzerland)

    Key finding: Neuroinflammation is associated with a large array of neurological disorders for which mitochondrial DAMPs could represent a common thread supporting disease progression.

  25. 2020-07-22

    Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer's Disease

    ✓ Peer-reviewed Genetics Cell

    Key finding: Although complex inflammatory-like alterations are observed around the amyloid plaques of Alzheimer's disease (AD), little is known about the molecular changes and cellular interactions that characterize this response. +4 more findings

Browse the library by subject, with the full score breakdown →